BioCentury
ARTICLE | Company News

BioNovion, Genmab deal

March 2, 2015 8:00 AM UTC

Genmab partnered with BioNovion to co-develop and co-commercialize bispecific antibodies targeting immune checkpoints. Both companies will contribute panels of antibodies to create the candidates usin...